Kadimastem plans listing on Nasdaq through merger
The Israeli biotech stem cell company will delist from the TASE.
Source: globes.co.il
Fast, Ad-Free News Updates
Stay updated with breaking news from Adi Wolf. Real-time updates on events, politics, business and more.